Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 38 (1), 1-13

Neuropeptide Regulation of Signaling and Behavior in the BNST


Neuropeptide Regulation of Signaling and Behavior in the BNST

Thomas L Kash et al. Mol Cells.


Recent technical developments have transformed how neuroscientists can probe brain function. What was once thought to be difficult and perhaps impossible, stimulating a single set of long range inputs among many, is now relatively straight-forward using optogenetic approaches. This has provided an avalanche of data demonstrating causal roles for circuits in a variety of behaviors. However, despite the critical role that neuropeptide signaling plays in the regulation of behavior and physiology of the brain, there have been remarkably few studies demonstrating how peptide release is causally linked to behaviors. This is likely due to both the different time scale by which peptides act on and the modulatory nature of their actions. For example, while glutamate release can effectively transmit information between synapses in milliseconds, peptide release is potentially slower [See the excellent review by Van Den Pol on the time scales and mechanisms of release (van den Pol, 2012)] and it can only tune the existing signals via modulation. And while there have been some studies exploring mechanisms of release, it is still not as clearly known what is required for efficient peptide release. Furthermore, this analysis could be complicated by the fact that there are multiple peptides released, some of which may act in contrast. Despite these limitations, there are a number of groups making progress in this area. The goal of this review is to explore the role of peptide signaling in one specific structure, the bed nucleus of the stria terminalis, that has proven to be a fertile ground for peptide action.

Keywords: CRF; NPY; connectivity; extended amygdala; signaling.

Similar articles

See all similar articles

Cited by 27 PubMed Central articles

See all "Cited by" articles


    1. Adrian T.E., Allen J.M., Bloom S.R., Ghatei M.A., Rossor M.N., Roberts G.W., Crow T.J., Tatemoto K., Polak J.M. Neuropeptide Y distribution in human brain. Nature. 1983;306:584–586. - PubMed
    1. Allen Y.S., Adrian T.E., Allen J.M., Tatemoto K., Crow T.J., Bloom S.R., Polak J.M. Neuropeptide Y distribution in the rat brain. Science. 1983;221:877–879. - PubMed
    1. Almli L.M., Mercer K.B., Kerley K., Feng H., Bradley B., Conneely K.N., Ressler K.J. ADCYAP1R1 genotype associates with post-traumatic stress symptoms in highly traumatized African-American females. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2013;162B:262–272. - PMC - PubMed
    1. Aragam N., Wang K.S., Pan Y. Genome-wide association analysis of gender differences in major depressive disorder in the Netherlands NESDA and NTR population-based samples. J. Affect Disord. 2011;133:516–521. - PubMed
    1. Arzt E., Holsboer F. CRF signaling, molecular specificity for drug targeting in the CNS. Trends Pharmacol. Sci. 2006;27:531–538. - PubMed

Publication types